Glycemic control and self-monitoring of blood glucose in Chinese patients with type 2 diabetes on insulin: Baseline results from the COMPASS study. (February 2016)

• Record Type: Journal Article
• Authors: Ji, L; Su, Q; Feng, B; Shan, Z; Hu, R; Xing, X; Xue, Y
• Is Part Of: Diabetes research and clinical practice. Volume 112(2016)
• Page Start: 82
• Page End: 87
• Publication Date: 2016-02
• Subjects: Type 2 diabetes -- Insulin -- SMBG; Diabetes -- Periodicals; Diabetes Mellitus -- Periodicals; 616.462
• DOI: 10.1016/j.diabres.2015.08.005
• Languages: English
• ISSNs: 0168-8227

Abstract

Highlights: Overall poor level of glycemic control (mean HbA1c 8.48%). Low utilization of self-monitoring blood glucose in insulin-treated Chinese type 2 diabetics. Approximately two-thirds of patients report irregular self-monitoring of blood glucose. Most patients occasionally, rarely or never follow self-monitoring blood glucose instructions. Abstract: Aims: Self monitoring of blood glucose (SMBG) is not widely utilized in insulin-treated patients with type 2 diabetes. In this analysis, we evaluated the current state of SMBG in Chinese adults with type 2 diabetes treated with insulin. Methods: The 2-phase COMPASS study involved 24 centers across 10 provinces and cities in China. In the first phase, a cross sectional survey was carried out in type 2 diabetes patients receiving insulin treatment. The inclusion criteria for the study subjects in the first phase were: type 2 diabetes, insulin treatment for ≥3 months, and age ≥18 years. Evaluation was made on the status of SMBG and insulin therapy in these patients by a questionnaire. Results: A total of 2819 patients (age 58.2 ± 10.8 years; 49.6% females; BMI 24.6 ± 3.4 kg/m 2 ) with insulin-treated type 2 diabetes were recruited in phase I of this study. The majority of patients (80.4%) were receiving insulin treatment for at least 6 months. At baseline, the mean HbA1c was 8.5 ± 1.9% and 54.6% of patients had an HbA1c above 8%. 50.4% of the cohort had diabetes for at least 10 years, and fewer of these patients achieved HbA1c <7.0% (53 mmol/mol). At baseline, 65.8% of patients reported that daily SMBG frequency was performed on a random basis. 59.2% of patients reported that they occasionally, rarely or never follow their physician's instructions regarding SMBG. Hypoglycemia occurred in over 50% of patients, although in 71.8% of patients this was a rare occurrence. Conclusions: There is low utilization of SMBG in Chinese adults with insulin-treated type 2 diabetes, with approximately two-thirds of patients reporting irregular use of SMBG. This is in line with an overall poor level of glycemic control.